Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePembrolizumab Combo Yields Survival Benefit in Endometrial Cancer.SubjectsTHERAPEUTIC use of monoclonal antibodies; PLACEBOS; PROGRAMMED death-ligand 1; CANCER chemotherapy; ENDOMETRIAL tumors; MEDICAL research; PROGRESSION-free survival; OVERALL survivalPublicationOncology (08909091), 2024, Vol 38, Issue 5, p204ISSN0890-9091Publication typeArticle